UK Covid: Van-Tam says AstraZeneca vaccine ’s risk v benefit is finely balanced for younger people – as it happened

Deputy chief medical officersays benefits for older age groups clear, but adults under 30should be offered an alternative to AstraZeneca jab. This live blog is now closed -please follow the global live blog for coronavirus updatesUnder-30s in UK should be offered alternative to AstraZeneca jabUnder-30s may have ‘small delay’ in getting Covid jab, says Van-TamRisks v benefits of Oxford/AstraZeneca vaccine by age groupRare blood clot risk after AZ jab about four cases per million, says MHRAThird of severe Covid survivors diagnosed with mental health conditionOnly 3% of SNP supporters would back Alba party, poll suggests6.06pmBSTBut you can see that at a very low exposure risk ... the risk-benefit is relatively finely balanced in those younger age groups.Over 1 in 10 adults have now been fully vaccinated across the UKI want to thank the whole team involved - the NHS, armed forces, councils, scientists, volunteers, pharmacists& the British public.This is a mammoth team effort.pic.twitter.com/kslub4kQQURelated:Coronavirus live: EMA finds possible link between AZ jab and rare blood clots; record cases in France ICUs5.27pmBSTThe UK has recorded 45 further coronavirus deaths and 2,763 new cases, according to the latest update to the government ’s dashboard.Continue reading...
Source: Guardian Unlimited Science - Category: Science Authors: Tags: Coronavirus Politics UK news Vaccines and immunisation Health Boris Johnson Medical research NHS Jeremy Hunt Keir Starmer Scotland Alex Salmond Scottish National party (SNP) Alba Science Scottish politics Source Type: news